Haematologica

Keyphrases

Publications

volume 109, number 9, 2024

Caterina Cafaro, Zain Ali, Antton Lamarca, Daniela Torres Di Bello, Laura Duran Lozano, Ludvig Ekdahl, Malte Thodberg, Maroulio Pertesi, Aitzkoa Lopez De Lapuente Portilla, Björn Nilsson
The insertion/deletion polymorphism rs201494641 at ITGA9 influences blood CD34 + cell levels by altering ZNF384 binding. Haematologica 109 (9) (2024)
Kostas Pantopoulos
Oral iron supplementation: new formulations, old questions. Haematologica 109 (9) (2024)
Mitchell S Cairo
TP53 binding domain mutations are bad news in Burkitt lymphoma. Haematologica 109 (9) (2024)
Ryan Urak, Saghar Pahlavanneshan, Brenna Gittins, Ryotaro Nakamura, John A Zaia, John H Baird, Mary C Clark, Stephen J Forman, Xiuli Wang
Simultaneous targeting of B-cell malignancies and human immunodeficiency virus with bispecific chimeric antigen receptor T cells. Haematologica 109 (9) (2024)
Joel Wight, Piers Blombery, Jennifer Lickiss, Melinda Burgess, Clare Gould, Adrian Minson, Fiona Swain, Muhammed B Sabdia, Maher K Gandhi, Andrew Birchley, Colm Keane, Eliza A Hawkes
Systemic diffuse large B-cell lymphoma involving the central nervous system has high rates of defective antigen presentation and immune surveillance. Haematologica 109 (9) (2024)
Martin Stanulla
From niche to blockbuster: a greater role for allopurinol in maintenance treatment of acute lymphoblastic leukemia. Haematologica 109 (9) (2024)
Loic Renaud, Juliette Wencel, Arnaud Pagès, Ahmad Al Jijakli, Hannah Moatti, Laurent Quero, Vincent Camus, Pauline Brice
Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma. Haematologica 109 (9) (2024)
Xin Jin, Rui Sun, Zhu Li, Xianwu Wang, Xia Xiong, Wenyi Lu, Hairong Lyu, Xia Xiao, Yunpeng Tian, Hongkai Zhang, Zhihong Fang, Luqiao Wang, Mingfeng Zhao
CD22-targeted glyco-engineered natural killer cells offer a further treatment option for B-cell acute lymphoblastic leukemia. Haematologica 109 (9) (2024)
Chengfeng Bi, Yuhua Huang, Roshia Ali, Fang Wang, Xia Yang, Alyssa Bouska, Lu Xu, Xinbao Hao, Matthew A Lunning, Wing C Chan, Javeed Iqbal, Dennis D Weisenburger, Julie M Vose, Kai Fu
MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications. Haematologica 109 (9) (2024)
Leon Cords, Christoph Schaefers, Abdulaziz Kamili, Christian Hoffmann, Sophia Cichutek, Friedrich Haag, Susanne Polywka, Carsten Bokemeyer, Lisa Leypoldt, Winfried Alsdorf, Julian Schulze Zur Wiesch, Katja C Weisel
BCMA x CD3 T-cell engager in a patient with pentarefractory multiple myeloma and HIV: a clinical and immunological report. Haematologica 109 (9) (2024)
Paola Ghione, Gilles Salles
Spotlight on polatuzumab vedotin: new standards for diffuse large B-cell lymphoma? Haematologica 109 (9) (2024)
Haley Newman, Mary Egan Clark, Derek Wong, Jinhua Wu, Garrett M Brodeur, Stephen P Hunger, Sarah K Tasian, Timothy Olson, Julia T Warren, David T Teachey, Kira Bona, Jeffrey Schubert, Netta Golenberg, Maha Patel, Elizabeth H Denenberg, Elizabeth A Fanning, Jiani Chen, Tamara Luke, Sarah Charles, Daniel Gallo, Kajia Cao, Weixuan Fu, Zhiqian Fan, Lea F Surrey, Gerald Wertheim, Minjie Luo, Suzanne P MacFarland, Marilyn M Li, Yiming Zhong
Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumoronly versus paired tumor-normal sequencing. Haematologica 109 (9) (2024)
Jenna L Nunn, Christopher J Fraser
Refining risk stratification to improve prognosis in juvenile myelomonocytic leukemia. Haematologica 109 (9) (2024)
William T Johnson, Zachary D Epstein-Peterson, Nivetha Ganesan, Timothy Pak, Tiffany Chang, Phuong Dao, Alison J Moskowitz, Robert N Stuver, Paola Ghione, Natasha Galasso, Niloufer Khan, M Lia Palomba, Philip C Caron, Anita Kumar, Roni Tamari, Jennifer K Lue, Ariela Noy, Lorenzo Falchi, Andrew M Intlekofer, Boglarka Gyurkocza, Miguel-Angel Perales, Michael Scordo, A Zara Herskovits, Gilles Salles, Santosha A Vardhana, Steven M Horwitz
Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis. Haematologica 109 (9) (2024)
Amber Gibson, Cesar Nunez, Lindsay Robusto, Brianna Kammerer, Miriam Garcia, Michael Roth, Rachna Sheth, Priti Tewari, Aline Hittle, Laurie Toepfer, Romeo Torres, Nicholas J Short, Elias Jabbour, Nitin Jain, Branko Cuglievan, David McCall
Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica 109 (9) (2024)
Wei Huang, Yan Zou, Kun Zhang, Shi Yao, Shi-Hao Tang, Hao Wu, Peng-Fei Wang, Han-Zhong Xue, Tie-Lin Yang, Kun Zhang, Yan Guo
Two-sample Mendelian randomization analysis reveals causal relationships between blood lipids and venous thromboembolism. Haematologica 109 (9) (2024)
Nada Maaziz, François Girodon
Red cell mass measurement is still useful for the management of myeloproliferative neoplasms. Comment to "Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes Myeloprolifératifs". Haematologica 109 (9) (2024)
Alvaro J Alencar, Juan Pablo Alderuccio
Not all central nervous system lymphomas are created equal. Haematologica 109 (9) (2024)
Nikolaj Mannering, Dennis Lund Hansen, Anton Pottegård, Kjeld Andersen, Henrik Frederiksen
Mental health and use of psychotropic prescription drugs in adult patients with primary immune thrombocytopenia: a nationwide population-based cohort study. Haematologica 109 (9) (2024)
Steven M Holland
Non-tuberculous mycobacterial infections in hematology-oncology: we need to look harder. Haematologica 109 (9) (2024)
Chi Zhang, Kathy Yuen Yee Chan, Wing Hei Ng, John Tak Kit Cheung, Qiwei Sun, Han Wang, Po Yee Chung, Frankie Wai Tsoi Cheng, Alex Wing Kwan Leung, Xiao-Bing Zhang, Po Yi Lee, Siu Ping Fok, Guanglan Lin, Ellen Ngar Yun Poon, Jian-Hua Feng, Yan-Lai Tang, Xue-Qun Luo, Li-Bin Huang, Wei Kang, Patrick Ming Kuen Tang, Junbin Huang, Chun Chen, Junchao Dong, Ester Mejstrikova, Jiaoyang Cai, Yu Liu, Shuhong Shen, Jun J Yang, Patrick Man Pan Yuen, Chi Kong Li, Kam Tong Leung
CD9 shapes glucocorticoid sensitivity in pediatric B-cell precursor acute lymphoblastic leukemia. Haematologica 109 (9) (2024)
Roman Krzysiek, Samuel Bitoun, Rakiba Belkhir, Salima Hacein-Bey-Abina, Xavier Mariette
Clonal CD8 + T-cell expansion is associated with complete response to elranatamab in refractory multiple myeloma. Haematologica 109 (9) (2024)
Morgane Denis, Leah Swartzrock, Hana Willner, Quenton R Bubb, Ethan Haslett, Yan Yi Chan, Anzhi Chen, Mark R Krampf, Agnieszka D Czechowicz
Hematopoiesis after anti-CD117 monoclonal antibody treatment in the settings of wild-type and Fanconi anemia mice. Haematologica 109 (9) (2024)
Gaia Martire, Federica Lovisa, Elisa Carraro, Domenico Rizzato, Simone Cesaro, Rosa Maria Mura, Annalisa Tondo, Cinzia Bertolin, Francesca Boaretto, Leonardo Salviati, Alessandra Biffi, Marta Pillon, Lara Mussolin
TP53 DNA binding domain mutational status and rituximabbased treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification. Haematologica 109 (9) (2024)
Lydian A De Ligt, Karin Fijnvandraat, Bart J Biemond, Harriet Heijboer
Withholding transfusion therapy in children with sickle cell disease with abnormal transcranial Doppler and normal magnetic resonance angiography: a retrospective analysis. Haematologica 109 (9) (2024)
Peicheng Wang, Wanzhi Jiang, Tianyi Lai, Qi Liu, Yingying Shen, Baodong Ye, Dijiong Wu
Germline variants in acquired aplastic anemia: current knowledge and future perspectives. Haematologica 109 (9) (2024)
Yingsi Lu, Qingqing Zhu, Yun Wang, Meiling Luo, Junbin Huang, Qian Liang, Lifen Huang, Jing Ouyang, Chenxin Li, Nannan Tang, Yan Li, Tingting Kang, Yujia Song, Xiaoyu Xu, Liping Ye, Guoxing Zheng, Chun Chen, Chengming Zhu
Enhancement of PRMT6 binding to a novel germline GATA1 mutation associated with congenital anemia. Haematologica 109 (9) (2024)
Paolo Sportoletti
The discovery of NPM1 mutations in acute myeloid leukemia. Haematologica 109 (9) (2024)
Yuga Mizuno, Toru Kawakami, Daigo Higano, Shotaro Miyairi, Ami Asakura, Fumihiro Kawakami, Keijiro Sato, Shuji Matsuzawa, Sayaka Nishina, Hitoshi Sakai, Yumiko Higuchi, Kazuyuki Matsuda, Hideyuki Nakazawa, Fumihiro Ishida
CCL22 mutations in large granular lymphocytic leukemia. Haematologica 109 (9) (2024)
Jonatan Källström, Riita Niinimäki, Johan Fredlund, Hartmut Vogt, Laura Korhonen, Anders Castor, Josefine Palle, Arja Harila, Magnus Borssén, Jonas Abrahamsson, Torben Ek
Effects of allopurinol on 6-mercaptopurine metabolism in unselected patients with pediatric acute lymphoblastic leukemia: a prospective phase II study. Haematologica 109 (9) (2024)
Matthias Papo, Jérôme Razanamahéry, Malik Da Silva, Zofia Hélias-Rodzewicz, Vsevolod Potapenko, Suzanna Bota, Vanessa Leguy-Seguin, Stéphane Dominique, Raphaël Lhote, Quentin Moyon, Dov Taïeb, Tom Abrassart, Marion Campana, Visal Keo, Etienne Rivière, Olivier Lucidarme, Fleur Cohen-Aubart, Zahir Amoura, Julien Haroche, Jean-François Emile
Clinical phenotype of adult-onset systemic histiocytosis harboring BRAF in-frame deletions. Haematologica 109 (9) (2024)
Michelle Pradier, Tzu-Fei Wang, Deborah M Siegal, Grégoire Le Gal, Marc Carrier, Aurélien Delluc
Safety of outpatient management of cancer-associated pulmonary embolism: a retrospective study. Haematologica 109 (9) (2024)
Francesca Elice, Roberta Sommaggio, Elisa Cappuzzello, Marcello Riva, Maria Chiara Tisi, Martina Bernardi, Angela Bozza, Daniela Catanzaro, Katia Chieregato, Anna Merlo, Ilaria Giaretta, Anna Dalla Pieta, Mauro Krampera, Carlo Visco, Livio Trentin, Andrea Visentin, Alberto Tosetto, Giuseppe Astori, Antonio Rosato
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokineinduced killer cells: a first-in-human case report. Haematologica 109 (9) (2024)
Déborah Meyran, Chloé Arfeuille, Sylvie Chevret, Quentin Neven, Aurélie Caye-Eude, Elodie Lainey, Arnaud Petit, Fanny Rialland, Gérard Michel, Dominique Plantaz, Charlotte Jubert, Alexandre Theron, Virginie Gandemer, Marie Ouachée-Chardin, Catherine Paillard, Bénédicte Bruno, Nimrod Buchbinder, Cécile Pochon, Charlotte Calvo, Mony Fahd, André Baruchel, Hélène Cavé, Jean-Hugues Dalle, Marion Strullu
A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Haematologica 109 (9) (2024)
Sandrine Saugues, Céline Lambert, Elisabeth Daguenet, Gabrielle Roth-Guepin, Françoise Huguet, Pascale Cony-Makhoul, Hyacinthe Johnson Ansah, Martine Escoffre-Barbe, Ali Turhan, Philippe Rousselot, Andreï Tchirkov, Dalil Hamroun, Eric Hermet, Bruno Pereira, Marc G Berger
The initial molecular response predicts the deep molecular response but not treatment-free remission maintenance in a real-world chronic myeloid leukemia cohort. Haematologica 109 (9) (2024)
Bernward Zeller, Nira Arad-Cohen, Daniel Cheuk, Barbara De Moerloose, Jose M Fernandez Navarro, Henrik Hasle, Kirsi Jahnukainen, Kristian Lovvik Juul-Dam, Gertjan Kaspers, Zanna Kovalova, Olafur G Jonsson, Birgitte Lausen, Monica Munthe-Kaas, Ulrika Noren Nystrom, Josefine Palle, Ramune Pasauliene, Cornelis J Pronk, Kadri Saks, Anne Tierens, Jonas Abrahamsson
Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 protocol. Haematologica 109 (9) (2024)
Giovanna Russo, Raffaella Colombatti
Are we ready for new strategies to prevent stroke in children with sickle cell disease? Haematologica 109 (9) (2024)
Lisa V E Oostenbrink, Erik G J Von Asmuth, Cornelia M Jol-van der Zijde, Anja M Jansen-Hoogendijk, Carly Vervat, Robbert G M Bredius, Maarten J D Van Tol, Marco W Schilham, Petr Sedlacek, Marianne Ifversen, Adriana Balduzzi, Peter Bader, Christina Peters, Dirk Jan A R Moes, Arjan C Lankester
Anti-T-lymphocyte globulin exposure is associated with acute graft- versus -host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplantation: a multinational prospective study. Haematologica 109 (9) (2024)
Layal Yasin, Arndt Borkhardt
Do it once, but do it right. Haematologica 109 (9) (2024)
Gordon J Ruan, Xiaosheng Wu, Kimberly A Gwin, Michelle K Manske, Jithma P Abeykoon, Vaishali Bhardwaj, Taylor L Witter, Matthew J Schellenberg, Kari G Rabe, Neil E Kay, Sameer A Parikh, Thomas E Witzig
Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemia. Haematologica 109 (9) (2024)
Yigal Dror
Unfriendly protein of GATA1 and mechanisms of bone marrow failure. Haematologica 109 (9) (2024)
Yingsi Lu, Qingqing Zhu, Yun Wang, Meiling Luo, Junbin Huang, Qian Liang, Lifen Huang, Jing Ouyang, Chenxin Li, Nannan Tang, Yan Li, Tingting Kang, Yujia Song, Xiaoyu Xu, Liping Ye, Guoxing Zheng, Chun Chen, Chengming Zhu
Enhancement of PRMT6 binding to a novel germline GATA1 mutation associated with congenital anemia. Haematologica 109 (9) (2024)
Markus Perl, Konstantin Herfeld, Dennis C Harrer, Matthias Höpting, Marina Schweiger, Ulrich Sterz, Leonard Knödler, Susanne Heimerl, Leo Hansmann, Wolfgang Herr, Hendrik Poeck, Daniel Wolff, Matthias Edinger, Christina Hart, Matthias A Fante
Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies. Haematologica 109 (9) (2024)
Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Kosei Matsue
Prognostic relevance of tumor-infiltrating CD4 + cells and total metabolic tumor volume-based risk stratification in diffuse large B-cell lymphoma. Haematologica 109 (9) (2024)
Chengfeng Bi, Yuhua Huang, Roshia Ali, Fang Wang, Xia Yang, Alyssa Bouska, Lu Xu, Xinbao Hao, Matthew A Lunning, Wing C Chan, Javeed Iqbal, Dennis D Weisenburger, Julie M Vose, Kai Fu
MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications. Haematologica 109 (9) (2024)
Lyndsey Flanagan, Aisling Coughlan, Nicola Cosgrove, Andrew Roe, Yu Wang, Stephanie Gilmore, Izabela Drozdz, Claire Comerford, Jeremy Ryan, Emma Minihane, Salma Parvin, Michael O'Dwyer, John Quinn, Philip Murphy, Simon Furney, Siobhan Glavey, Tríona Ní Chonghaile, Leukemia Research Foundation, Science Foundation Ireland, Breakthrough Cancer Research
Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma. Haematologica 109 (9) (2024)
Guru Subramanian Guru Murthy, Antoine N Saliba, Aniko Szabo, Alexandra Harrington, Sameem Abedin, Karen Carlson, Laura Michaelis, Lyndsey Runaas, Arielle Baim, Alex Hinman, Sonia Maldonado-Schmidt, Annapoorna Venkatachalam, Karen S Flatten, Kevin L Peterson, Paula A Schneider, Mark Litzow, Scott H Kaufmann, Ehab Atallah
A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia. Haematologica 109 (9) (2024)
Lyndsey Flanagan, Aisling Coughlan, Nicola Cosgrove, Andrew Roe, Yu Wang, Stephanie Gilmore, Izabela Drozdz, Claire Comerford, Jeremy Ryan, Emma Minihane, Salma Parvin, Michael O'Dwyer, John Quinn, Philip Murphy, Simon Furney, Siobhan Glavey, Tríona Ní Chonghaile, Leukemia Research Foundation, Science Foundation Ireland, Breakthrough Cancer Research
Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma. Haematologica 109 (9) (2024)
Déborah Meyran, Chloé Arfeuille, Sylvie Chevret, Quentin Neven, Aurélie Caye-Eude, Elodie Lainey, Arnaud Petit, Fanny Rialland, Gérard Michel, Dominique Plantaz, Charlotte Jubert, Alexandre Theron, Virginie Gandemer, Marie Ouachée-Chardin, Catherine Paillard, Bénédicte Bruno, Nimrod Buchbinder, Cécile Pochon, Charlotte Calvo, Mony Fahd, André Baruchel, Hélène Cavé, Jean-Hugues Dalle, Marion Strullu
A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Haematologica 109 (9) (2024)
Jonatan Källström, Riita Niinimäki, Johan Fredlund, Hartmut Vogt, Laura Korhonen, Anders Castor, Josefine Palle, Arja Harila, Magnus Borssén, Jonas Abrahamsson, Torben Ek
Effects of allopurinol on 6-mercaptopurine metabolism in unselected patients with pediatric acute lymphoblastic leukemia: a prospective phase II study. Haematologica 109 (9) (2024)